PharmExec Webcasts

LIVE WEBCASTS

More webcasts coming soon!

 

 

ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY

 

Get Ready, Get Set: 10 Steps to Take during Study Start Up

Recorded on: January 20, 2015
Patient recruitment difficulties account for up to 45% of study delays.  Why not take advantage of the time before the site activation visit (SIV) to help prepare the site for patient enrollment?   Join us as we explore proven strategies to optimize study start-up and help sites reach enrollment goals. Our thought leaders will share a recent case study, illustrating the approach and outcome of each tactic

Register Free at http://www.pharmexec.com/startup

Sponsor:
UBC Express Scripts

 

Best Practices for a Successful Global Access Program

Recorded on: January 12, 2015
Join us as Clinigen and Cubist present best practices for developing and implementing a Global Access Program.  Learn how to engage the right stakeholders, operate within the regulatory framework and help patients in need.

 

Register Free at http://www.pharmexec.com/clinigen

Sponsor:
Clinigen

 

Avoid the Last Minute Rush – Planning Ahead for Successful Global Market Access

Recorded on: December 17, 2014
Do you have market access challenges (e.g. evidence generation planning) that you are facing, or might face in the next few years?  Join Terry Wilcox, Senior Research Leader, and Clark Paramore, Vice President, for Evidera insights into planning for successful global market access.

Register Free at http://www.pharmexec.com/evidencegen

Sponsor:
Evidera

 

Enhancing Patient Engagement - How to Maximize Nursing and Adherence Solutions

Recorded: November 20, 2014

Every day, pharmaceutical companies are challenged to develop cohesive patient support programs that properly engage patients throughout their experience with a product. Discover how you can benefit from recognizing the questions you should be asking and what you can do to keep patients engaged at every point of their health journey and your product lifecycle. Proven customized clinical programs that can help increase adherence will be discussed.

Register Free at http://www.pharmexec.com/patientengagement

Sponsor:
UBC Express Scripts

 

Market Access for Orphan Drugs in China

Recorded: November 18, 2014

A significant number of patients in China have rare / orphan diseases. As the priority of China’s health care reform recently moved to increase the depth of coverage, the number of critical diseases and the percentage of reimbursement by the state continue to increase. In this webinar, we will share with you the opportunities and challenges for orphan drugs to gain access to the patients in China and what a manufacturer could do to prepare for market access in China. 

Register Free at http://www.pharmexec.com/orphan

Sponsor:
Evidera

 

Improving Lab Efficiency Through New Mobility and Data Visualization Techniques

Recorded: October 29, 2014

Making the right decisions concerning how laboratory assets are deployed, utilized and managed throughout their lifecycle allows labs to make the proper choices and implement changes that will increase productivity, gain efficiencies and drive overall business improvement. This webinar explores the impact of mobile applications and visualizing instrument performance using new techniques with the objective of creating a more interactive and informative lab environment.

Register Free at http://www.pharmexec.com/labefficiency

Click here for downloadable/printable Infographic

Sponsor:
Perkin Elmer

 

Establishing Processes and Controls to Ensure an Inspection-ready TMF Every Day

Recorded: October 1, 2014

The MHRA recently updated its definition of a critical GCP finding to include TMFs that are not readily accessible or incomplete. It is difficult to achieve the right level of control and accessibility without the proper technology. Join PharmaStart’s Rebecca Moraris and Veeva’s Mike Burton to hear how PharmaStart implemented Veeva Vault eTMF to automate critical processes and provide their partners remote access to the TMF.

 

Register Free at http://www.pharmexec.com/inspection

Sponsor:
Veeva

 

New expensive treatments for hepatitis C infection: have US payers reached a tipping point?

Live broadcast: September 24, 2014 at 10AM EDT

The launch of Sovaldi® (sofosbuvir, Gilead) in the US earlier this year marked an important advance in the treatment of hepatitis C virus (HCV) infection, but its price –at $84,000 for a 12-week treatment course – has come under heavy scrutiny. Although downstream cost savings mean that Sovaldi® represents good value to payers over the long term, the product finds itself at the center of a growing debate about the future of drug pricing and cost containment in a health system struggling to cope with the escalating costs of specialty medications.

In this webinar, we ask if recent experience with HCV treatments would suggest payers have reached a tipping point in terms of their willingness or ability to accept high-priced, specialty drugs. We will examine the key dynamics in the HCV market, actions already taken by US payers to contain HCV treatment costs, what further strategies could be considered (taking the practicalities of the US system into account), and future implications for high-cost treatments.

Register Free at http://www.pharmexec.com/expensive

Sponsor:
Evidera

 

Engineer Your Business to Win in the Mobile Selling Moment

Live broadcast: September 25, 2014 at noon EDT

Mobile moments -- the expectation I can get what I want, anytime, in my immediate context -- is the new battleground for engaging employees and healthcare providers. If you're not there to provide an instant answer, you’ll lose.

Join guest speaker Ted Schadler of Forrester Research, Inc. as he outlines how to engineer your business to win the mobile moment. Also learn how Stryker Medical leapt ahead of the competition with mobile selling moments for their sales reps.

Register Free at http://www.pharmexec.com/mobileselling

Sponsor:
Prolifiq

 

Establishing Processes and Controls to Ensure an Inspection-ready TMF Every Day

Live broadcast: October 1, 2014 at 2pm EDT

The MHRA recently updated its definition of a critical GCP finding to include TMFs that are not readily accessible or incomplete. It is difficult to achieve the right level of control and accessibility without the proper technology. Join PharmaStart’s Rebecca Moraris and Veeva’s Mike Burton to hear how PharmaStart implemented Veeva Vault eTMF to automate critical processes and provide their partners remote access to the TMF.

Register Free at http://www.pharmexec.com/inspection

Sponsor:
Veeva

 

Are Your Patient Access Solutions Performing up to Your Expectations? Leveraging data and analytics to enhance performance

Recorded: August 6, 2014

Patient Access solutions must be supported by rich sources of evidence, demonstrations of convincing payback, and sophisticated predictive models. But how can you tell if your campaign is performing up to expectations?  And if it isn’t, do you have a strategy for mid-course correction? Paul LeVine and Robert Leedom leverage their deep-seated experience in the analytics that drive patient access to show you that you can identify and improve the performance of your patient access solutions through effective mid-course corrections.

Register Free at http://www.pharmexec.com/patientaccess

Sponsor:
TrialCard

 

Seeing the Whole Picture: Harnessing the Power of Data to Drive Smarter Marketing Decisions

Recorded: August 7, 2014

Learn how big data is revolutionizing how organizations measure the true impact of their digital marketing efforts. Join  leading experts in digital marketing and analytics as they share real-world insights on how new methods of data capture and integration are breaking down current barriers to individual channel analysis and giving marketers the ability to drive real performance improvements. 

Register Free at http://www.pharmexec.com/picture

Sponsor:
Ernst Young

Leveraging Analytics to Inform Payer Messaging: 3 Case Studies

Recorded: June 18, 2014

Market access is a key challenge for Specialty drugs today.  Join Cardinal Health Specialty Solution’s Chief Medical Officer, Dr. Bruce Feinberg, on June 18th at 2:00 PM EST for a provocative discussion of the importance of high-value analytics using real world data to create impactful market messages and ensure brand success.   

Register Free at http://www.pharmexec.com/payermessaging

Sponsor:
Cardinal Health

 

Top 10 Clinical Trial Cost-Cutting Innovations

Recorded: June 26, 2014

Clinical research experts continue to observe the rising costs and reduced efficiency of clinical studies. At the same time, today’s evolving healthcare landscape prioritizes empowering the patient. This combination has resulted in clinical research shifting towards a patient-centric model. Understanding these changes and implementing appropriate strategies is vital to improving outcomes.

Join the discussion as Ms. Erem Latif, Trial Enhancement Services, UBC, will share proven innovative and cost-cutting strategies to maximize the efficiency and effectiveness of clinical research.

Register Free at http://www.pharmexec.com/top10

Sponsor:
UBC Express Scripts

 

Methods for patient-centered endpoint selection in rare disease drug development programs

Recorded: July 23, 2014

While stakeholder groups have called for patient engagement in rare disease drug development programs, traditional methods for engaging patients in endpoint strategy are very often impossible due to the nature of rare diseases.  This webinar will review innovative methods for gathering patient input to inform endpoint selection and provide specific examples of successful solutions.

Register Free at http://www.pharmexec.com/endpoint

Sponsor:
Evidera

 

How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety

Recorded: May 14, 2014 from 11-noon Eastern

Attend this webcast to discover how innovations in digital medicine and electronic data capture enable accurate and timely insight into medication adherence during a clinical trial – helping to determine optimum dosing ranges and reducing clinical trial attrition, especially in Phase III trials. 

Register Free at http://www.pharmexec.com/pinpoint

Sponsor:
Oracle

Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements

Recorded on: March 19, 2014

Challenged by the need to gather real-world evidence to meet post-marketing payer and regulatory evidence requirements?

Dr. Janine Collins, Senior Director, European Risk Management, and Krista Payne, Executive Director, Sr. Research Scientist, Value Demonstration, will share current perspectives, opportunities, and challenges in relation to the impact of converging payer and regulator evidence requirements on PASS and PMR studies.

Register Free at http://www.pharmexec.com/evidence

Sponsor:
UBC Express Scripts

 

Overcoming the Life Sciences Content Conundrum in a Multichannel World
Recorded on: March 5, 2014

A must attend webinar for life sciences companies who are serious about driving a successful multichannel strategy by overcoming their promotional content challenges through a smarter end-to-end content management approach.  Hear from our experts, Jan van den Burg, VP Commercial Strategy at Veeva Systems and Chris Moore, Partner at Ernst & Young and Life Sciences Content Management & Analytics Expert. Learn  about the key factors for successful execution and the benefits you stand to gain, including enhanced marketing and brand cooperation, better scaling of content both globally and locally, remaining compliant across channels, all whilst lowering costs.

Register Free at http://www.pharmexec.com/multichannel

Sponsor:
Veeva

 

New Industry Research: Transforming Clinical R&D Strategy and Performance with Real-World Data
Recorded on: February 13, 2014

Join speakers from the Tufts Center for the Study of Drug Development, Oracle Health Sciences, and Context Matters to explore how protocol and trial designs can be optimized not only for greater R&D efficiency but also to discover health economic outcomes with clinical outcomes. 

Register Free at http://www.pharmexec.com/performance

Sponsor:
Oracle

 

Evaluation of EU Post-Authorization Safety Studies Using Recent EU-RMP Summary Data: Analysis, Trends, Implications
Recorded on: January 29, 2014

This Webcast will provide an overview of recent trends in EU PASS, including an analysis of a sample of EU-RMP summary data, description of PASS types requested and comparison/contrast of characteristics between drug types.

Implications for Pharmaceutical Companies and lessons learnt will be discussed

Register Free at http://www.pharmexec.com/eu_rmp

Sponsor:
Evidera